today announced its Phase 2 study failed to show treatment benefit in patients with chronic active pulmonary sarcoidosis. The Phase 2 RESOLVE-Lung study (NCT05314517) evaluated the efficacy and ...
The study enrolled 107 patients with pulmonary sarcoidosis considered to have chronic, active disease not well-controlled despite available therapeutic options. Patients in the study received a ...
The study enrolled 107 patients with pulmonary sarcoidosis considered to have chronic, active disease not well-controlled despite available therapeutic options. Patients in the study received a ...
Negative pressure pulmonary edema (NPPE) is a form of non-cardiogenic pulmonary ... Research involving 86,561 patients (13) revealed that active smokers and those undergoing endotracheal intubation ...
Background: Patients with diabetes face an increased risk of postoperative pulmonary infection (PPI). However, precise predictive models specific to this patient group are lacking. Objective: To ...
TREATMENT of experimental pulmonary edema with ethyl alcohol as an antifoaming agent has been described by Luisada. 1 However, no clinical experience with this agent has as yet appeared in the ...
© 2024 American Chemical Society and Division of Chemical Education, Inc. Article Views are the COUNTER-compliant sum of full text article downloads since November ...
Negative-pressure pulmonary edema (NPPE) occurs when a large, negative intrathoracic pressure is generated against an obstructed upper airway, causing fluid to shift into the lung interstitium.
Small-Text provides state-of-the-art Active Learning for Text Classification. Several pre-implemented Query Strategies, Initialization Strategies, and Stopping Critera are provided, which can be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback